What does a reactive 41‑kDa IgG band on a Lyme disease Western blot indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Does a Reactive 41 kDa IgG Band Mean?

A reactive 41 kDa IgG band alone does NOT indicate Lyme disease and should not be interpreted as evidence of infection. This band represents antibodies against Borrelia burgdorferi flagellin protein but is highly cross-reactive with other bacterial flagellar proteins and was found in 43% of healthy controls with minimal Lyme disease exposure risk 1.

Why This Band Is Not Diagnostic

The 41 kDa band is problematic for several critical reasons:

  • High false-positive rate: This antibody cross-reacts extensively with non-Borrelial bacterial flagellar proteins, making it one of the least specific bands on the Western blot 1
  • Common in healthy individuals: Studies demonstrate reactivity in nearly half of healthy controls without Lyme disease exposure 1, 2
  • Early but non-specific response: While the 41 kDa flagellin is the major protein component of B. burgdorferi and triggers early immune responses, its presence alone lacks diagnostic specificity 3, 4, 5

CDC Diagnostic Criteria You Must Follow

For a positive IgG Western blot result, you need ≥5 of 10 specific CDC-recommended bands, not just one band 6. The presence of fewer than 5 IgG bands does not constitute a positive result 1, 6.

The CDC-recommended approach requires:

  • First-tier test: EIA/ELISA screening must be positive or equivocal before proceeding to Western blot 6
  • Second-tier confirmation: IgG Western blot requires at least 5 specific bands for positivity 6
  • Critical pitfall: Interpreting a single IgM band or <5 IgG bands as positive is a common diagnostic error that leads to misdiagnosis 1, 6

Clinical Context Matters

The interpretation depends entirely on your clinical scenario:

  • If symptoms <30 days: Both IgM and IgG Western blots should be performed if the first-tier test is positive, but strict band criteria must still be met 6
  • If symptoms >30 days: Only IgG Western blot should be performed, as IgM testing beyond 4-8 weeks is not clinically interpretable 6
  • With erythema migrans rash: Clinical diagnosis supersedes serology—treat based on clinical presentation without waiting for serologic confirmation 6

What You Should Do

Report this as a negative serological result 1, 6. A single 41 kDa IgG band does not meet CDC criteria for Lyme disease diagnosis and should not influence clinical decision-making unless:

  • The patient has characteristic erythema migrans with appropriate epidemiologic exposure (diagnose clinically without serology) 6
  • There is strong clinical suspicion with short disease duration (consider serological follow-up in 2-4 weeks) 1
  • The first-tier EIA/ELISA was negative (in which case Western blot should not have been performed) 6

Common Pitfalls to Avoid

  • Do not treat based on this result alone: Overinterpreting insufficient bands leads to reduced specificity and potential misdiagnosis 1
  • Do not order Western blot without positive screening test: The two-tiered approach only works when tests are performed in succession 1
  • Do not assume any reactivity equals infection: The 41 kDa band's cross-reactivity with other bacteria makes it diagnostically unreliable as a standalone finding 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.